P57.02 Integration of Systemic / Tumor PD-L1 as a Predictive Biomarker of Clinical Outcome in Advanced NSCLC Patients Treated With Anti-PD-(L)1 Agents
Anguera Palacios, G., Zamora Atenza, C., Riudavets Melià, M., Alserawan De Lamo, L., Sullivan, I., Barba Joaquín, A., Serra Lopez, J., Ortiz, M.A., Mulet, M., Vidal Alcorisa, S., Majem, M.
Published in Journal of thoracic oncology (01.10.2021)
Published in Journal of thoracic oncology (01.10.2021)
Get full text
Journal Article
P1.07-028 Determination of Soluble PD-L1 as a Potential Biomarker for Anti-PD(L)1 Therapy in Non-Small Cell Lung Cancer (NSCLC)
Joaquín, A. Barba, Atenza, C. Zamora, Alcorisa, S. Vidal, Sullivan, I., Palacios, G. Anguera, De Juana, M.a. Ortiz, Granyò, M. Andrés, Manrique, A. Virgili, Cid, N. Dueñas, Casado, A. Vethencourt, Del Carpio Huerta, L., Pons, P. Gomila, Arellano, S. Camacho, Asensio, S. Moron, Melia, M. Riudavets, Valiente, C. Molto, Perez, A. Callejo, Tarruella, M. Majem
Published in Journal of thoracic oncology (01.11.2017)
Published in Journal of thoracic oncology (01.11.2017)
Get full text
Journal Article